지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2009.1
- 수록면
- 153 - 166 (14page)
이용수
초록· 키워드
오류제보하기
The development of prevention therapies for Alzheimer’s disease (AD) would greatly benefit
from biomarkers that are sensitive to the subtle brain changes that occur in the preclinical stage
of the disease. Reductions in the cerebral metabolic rate of glucose (CMRglc), a measure of
neuronal function, have proven to be a promising tool in the early diagnosis of AD. In vivo
brain 2-[
18
F]fluoro-2-Deoxy-D-glucose-positron emission tomography (FDG-PET) imaging demonstrates consistent and progressive CMRglc reductions in AD patients, the extent and topography of which correlate with symptom severity. There is increasing evidence that hypometabolism appears during the preclinical stages of AD and can predict decline years before
the onset of symptoms. This review will give an overview of FDG-PET results in individuals at
risk for developing dementia, including: presymptomatic individuals carrying mutations responsible for early-onset familial AD; patients with Mild Cognitive Impairment (MCI), often a
prodrome to late-onset sporadic AD; non-demented carriers of the Apolipoprotein E (ApoE) ε4
allele, a strong genetic risk factor for late-onset AD; cognitively normal subjects with a family
history of AD; subjects with subjective memory complaints; and normal elderly followed longitudinally until they expressed the clinical symptoms and received post-mortem confirmation of
AD. Finally, we will discuss the potential to combine different PET tracers and CSF markers of
pathology to improve the early detection of AD.
목차
등록된 정보가 없습니다.
참고문헌 (24)
참고문헌 신청
Arriagada PV / 1992 / Distribution of Alzheimertype pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer’s disease / Neurology 4 : 1681 ~
Braak H / 1991 / Neuropathological stageing of Alzheimer-related changes / Acta Neuropathol 82 : 239 ~ 259
Braak H / 1996 / Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis / Acta Neuropathol 92 : 197 ~ 201
Consensus report of the Working Group on / 1998 / “Molecular and Biochemical Markers of Alzheimer’s Disease”. The Ronald and Nancy Reagan Research Institute of the Alzhei
Delacourte A / 1999 / The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease / Neurol 52 : 1158 ~ 1165
Braak H / 1991 / Neuropathological stageing of Alzheimer-related changes / Acta Neuropathol 82 : 239 ~ 259
Braak H / 1996 / Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis / Acta Neuropathol 92 : 197 ~ 201
Consensus report of the Working Group on / 1998 / “Molecular and Biochemical Markers of Alzheimer’s Disease”. The Ronald and Nancy Reagan Research Institute of the Alzhei
Delacourte A / 1999 / The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease / Neurol 52 : 1158 ~ 1165
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Clinical Characteristics and Genetic Variations in Early-Onset Atopic Dermatitis Patients
Annals of Dermatology
2019 .01
-
하기도 감염 환아에서 분리된 Adenovirus 1, 2, 5 혈청형의 유전체형 분석
Pediatric Infection and Vaccine
2005 .01
-
Biomarkers Predicting Alzheimer’s Disease in Cognitively Normal Aging
Journal of Clinical Neurology
2011 .01
-
Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer’s Disease
Clinical Psychopharmacology and Neuroscience
2011 .01
-
Metabolism-Centric Overview of the Pathogenesis of Alzheimer’s Disease
Yonsei Medical Journal
2017 .01
-
The Prevalence and Risk Factors of Atopic Dermatitis and Clinical Characteristics according to Disease Onset in 19-Year-Old Korean Male Subjects
Annals of Dermatology
2018 .01
-
Association of Alzheimer's Disease with the Risk of Developing Epilepsy: a 10-Year Nationwide Cohort Study
Dementia and Neurocognitive Disorders(대한치매학회지)
2018 .01
-
알츠하이머병 환자에서 해마 위축과 정신병적 증상
신경정신의학
2018 .01
-
Clinical Usefulness of 18F-FC119S Positron-Emission Tomography as an Auxiliary Diagnostic Method for Dementia: An Open-Label, Single-Dose, Evaluator-Blind Clinical Trial
Journal of Clinical Neurology
2020 .01
-
Cerebrospinal Biomarker Cut-off Methods Defined Only by Alzheimer’s Disease Predict More Precisely Conversions of Mild Cognitive Impairment
Dementia and Neurocognitive Disorders(대한치매학회지)
2017 .01
-
아토피 피부염 환아의 정신 건강 분석 및 아토피 피부염 교육을 통한 인식, 인지도 개선에 대한 고찰
한방안이비인후피부과학회지
2017 .01
-
Stem Cell Therapy: A Prospective Treatment for Alzheimer’s Disease
PSYCHIATRY INVESTIGATION
2016 .01
-
아토피피부염의 치료 및 관리 실태
천식 및 알레르기
2012 .01
-
Pure Word Deafness in a Patient with Early-Onset Alzheimer’s Disease: An Unusual Presentation
Journal of Clinical Neurology
2011 .01
-
Structural MRI and Amyloid PET Imaging for Prediction of Conversion to Alzheimer’s Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis
PSYCHIATRY INVESTIGATION
2017 .01
-
Blood Pressure and Heart Rate Variability in Alzheimer’s Disease
Dementia and Neurocognitive Disorders(대한치매학회지)
2015 .01
-
Alzheimer's Disease Diagnosis Using Misfolding Proteins in Blood
Dementia and Neurocognitive Disorders(대한치매학회지)
2020 .01
-
A Family-Engaged Educational Program for Atopic Dermatitis: A Seven-Year, Multicenter Experience in Daegu-Gyeongbuk, South Korea
Annals of Dermatology
2015 .01
-
아토피피부염의 변증과 평가방법에 대한 고찰
한방안이비인후피부과학회지
2008 .01
-
Single Photon Emission Computerized Tomography and Neuropsychological Tests That Predict a Good Response to Donepezil Therapy for Alzheimer’s Disease
Dementia and Neurocognitive Disorders(대한치매학회지)
2015 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0